Kiniksa Pharmaceuticals Ltd (KNSA)
20.08
+0.70
(+3.61%)
USD |
NASDAQ |
May 03, 16:00
20.08
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Total Liabilities (Quarterly): 87.78M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 87.78M |
| December 31, 2023 | 87.48M |
| September 30, 2023 | 77.94M |
| June 30, 2023 | 72.68M |
| March 31, 2023 | 52.77M |
| December 31, 2022 | 63.52M |
| September 30, 2022 | 75.94M |
| June 30, 2022 | 57.08M |
| March 31, 2022 | 64.72M |
| December 31, 2021 | 47.76M |
| September 30, 2021 | 38.81M |
| June 30, 2021 | 43.42M |
| March 31, 2021 | 40.46M |
| Date | Value |
|---|---|
| December 31, 2020 | 37.53M |
| September 30, 2020 | 25.90M |
| June 30, 2020 | 21.02M |
| March 31, 2020 | 20.27M |
| December 31, 2019 | 29.11M |
| September 30, 2019 | 29.89M |
| June 30, 2019 | 32.94M |
| March 31, 2019 | 39.64M |
| December 31, 2018 | 42.70M |
| September 30, 2018 | 28.19M |
| June 30, 2018 | 23.33M |
| March 31, 2018 | 19.30M |
| December 31, 2017 | 137.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
20.27M
Minimum
Mar 2020
87.78M
Maximum
Mar 2024
50.35M
Average
45.59M
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 617.71M |
| Geron Corp | 137.21M |
| United Therapeutics Corp | 1.157B |
| Vanda Pharmaceuticals Inc | 103.53M |
| TG Therapeutics Inc | 213.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 519.67M |
| Shareholders Equity (Quarterly) | 431.90M |
| Current Ratio | 4.214 |